Renaissance Technologies (RenTech)'s COGT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 706,268 shares of Cogent Biosciences, Inc. (COGT) worth $27.18 M, representing 0.04% of the portfolio. First purchased in 2020-Q4, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in COGT, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 456,100 shares. Largest reduction occurred in Q2 2024, reducing 299,668 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Cogent Biosciences (COGT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Cogent Biosciences (COGT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +17,200 | Add 2.50% | 706,268 | $38.49 |
| Q4 2025 | +456,100 | Add 195.78% | 689,068 | $35.52 |
| Q3 2025 | +232,968 | New Buy | 232,968 | $14.36 |
| Q2 2025 | -254,768 | Sold Out | 0 | $0.00 |
| Q1 2025 | +11,839 | Add 4.87% | 254,768 | $5.99 |
| Q4 2024 | +242,929 | New Buy | 242,929 | $7.80 |
| Q2 2024 | -299,668 | Sold Out | 0 | $0.00 |
| Q1 2024 | +273,400 | Add 1040.81% | 299,668 | $6.72 |
| Q4 2023 | +26,268 | New Buy | 26,268 | $5.86 |
| Q2 2023 | -61,468 | Sold Out | 0 | $0.00 |
| Q1 2023 | +61,468 | New Buy | 61,468 | $0.01 |
| Q4 2022 | -15,168 | Sold Out | 0 | $0.00 |
| Q3 2022 | -26,632 | Reduce 63.71% | 15,168 | $14.90 |
| Q2 2022 | +30,300 | Add 263.48% | 41,800 | $9.02 |
| Q1 2022 | +11,500 | New Buy | 11,500 | $7.48 |
| Q1 2021 | -32,445 | Sold Out | 0 | $0.00 |
| Q4 2020 | +32,445 | New Buy | 32,445 | $11.22 |
Renaissance Technologies (RenTech)'s Cogent Biosciences Investment FAQs
Renaissance Technologies (RenTech) first purchased Cogent Biosciences, Inc. (COGT) in Q4 2020, acquiring 32,445 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Cogent Biosciences, Inc. (COGT) for 17 quarters since Q4 2020.
Renaissance Technologies (RenTech)'s largest addition to Cogent Biosciences, Inc. (COGT) was in Q4 2025, adding 689,068 shares worth $24.48 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 706,268 shares of Cogent Biosciences, Inc. (COGT), valued at approximately $27.18 M.
As of the Q1 2026 filing, Cogent Biosciences, Inc. (COGT) represents approximately 0.04% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Cogent Biosciences, Inc. (COGT) was 706,268 shares, as reported at the end of Q1 2026.